Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

454.00
-4.0500-0.88%
Post-market: 457.833.83+0.84%19:57 EDT
Volume:2.20M
Turnover:1.00B
Market Cap:115.19B
PE:29.63
High:461.05
Open:454.62
Low:452.89
Close:458.05
52wk High:513.98
52wk Low:362.50
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.61
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):15.32
EPS(LYR):15.32
ROE:22.54%
ROA:12.16%
PB:6.17
PE(LYR):29.63

Loading ...

Jun 05, 2019

Major Issues Report

Current report, items 5.02 and 5.07
Jun 04, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 04, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 04, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 04, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 04, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 04, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 04, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 04, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 01, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 30, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Dec 28, 2018

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Dec 26, 2018

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Oct 27, 2017

Major Issues Report

Feb 07, 2017

Correspondence

Jan 09, 2017

Major Issues Report

顶点医药公司/ MA
Jan 09, 2017

Major Issues Report

Dec 16, 2016

Correspondence

Oct 19, 2016

Correspondence

Oct 17, 2016

Correspondence